PleoPharma Secures NIH Grant for Phase 3 Cannabis Use
PleoPharma has been awarded a significant NIH grant to conduct a Phase 3 trial focused on cannabis use disorder. This trial aims to develop effective treatments for cannabis withdrawal, addressing a critical gap in clinical care. The pleopharma nih grant…
Cannabis’s Expanding Role Challenges California Sober
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
August 29 Cannabis News: Medical Marijuana Effects in Older
This article highlights new research on medical marijuana effects older adults, emphasizing benefits for chronic pain and sleep quality. The study provides valuable clinical insights for healthcare providers treating elderly patients. Understanding these…
Federal Rescheduling Sets The Stage For Marijuana Business
The recent federal rescheduling has set the stage for marijuana business acquisitions pharma and other industry players, signaling a major shift in cannabis market dynamics. This change could expand treatment options and foster new partnerships between…
CBD Reduces Pain From Burning Mouth Syndrome
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
91% of Seniors Report Relief From Medical Cannabis,
A Colombian study reveals promising results on cannabis cognitive health in seniors, with 91% reporting relief from pain, sleep disturbances, and mood disorders. These findings highlight potential benefits for older adults using medical cannabis.…
Study Reveals Only 14% of Colorado Recreational Marijuana
A recent study on colorado recreational marijuana compliance found that just 14% of products fully meet state regulations. This highlights significant concerns about product quality and safety for consumers and clinicians alike. Understanding these…
Exilby: FDA Fast-Tracks Cannabis-Derived Painkiller
The FDA's fast-tracking of cannabis-derived treatments Parkinson's evidence, such as VER-01, marks a pivotal advancement in pain management. This development offers promising alternatives to opioids, potentially transforming clinical approaches.…
Cannabis and Oral Spray Benefits for Restless Leg Syndrome
Recent clinical evidence shows that oral cannabis spray improves restless legs syndrome symptoms, providing relief for patients. CBD-dominant extracts also show potential in reducing related pain. This emerging treatment option may expand clinical…
Supply shortages, licensing delays slow Kentucky’s MMJ market
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…